Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Clinical and Translational Gastroenterology|February 10, 2022
Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus CirrhosisHamish Innes, Alex J Walker, Jennifer Benselin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2020
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver diseaseArjun N A Jayaswal, Christina Levick, Emmanuel A Selvaraj, et al.
Frontiers in Immunology|November 9, 2023
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescentsCecilia Jay, Emily Adland, Anna Csala, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccinesRosalind Rowland, Geraldine A O'Hara, Matthew Hamill, et al.
Science Translational Medicine|April 13, 2022
NK cells limit therapeutic vaccine-induced CD8<sup>+</sup>T cell immunity in a PD-L1-dependent mannerMariana O Diniz, Anna Schurich, Senthil K Chinnakannan, et al.
Science Immunology|August 29, 2025
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccinesSam M Murray, Ali Amini, Helen Ferry, et al.
Hepatology (Baltimore, Md.)|November 14, 2025
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategiesRebecca Strain, Matthew Edmans, Gerardo Montalvo Zurbia-Flores, et al.
The Journal of General Virology|September 28, 2012
Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6Hongren Wang, Zhiguo Yuan, Eleanor Barnes, et al.
The Lancet. Gastroenterology & Hepatology|November 28, 2018
Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trialStuart Flanagan, Jan Kunkel, Victoria Appleby, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UKVictoria Hamill, Will Gelson, Douglas MacDonald, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Clinical and Translational Gastroenterology|February 10, 2022
Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus CirrhosisHamish Innes, Alex J Walker, Jennifer Benselin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2020
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver diseaseArjun N A Jayaswal, Christina Levick, Emmanuel A Selvaraj, et al.
Frontiers in Immunology|November 9, 2023
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescentsCecilia Jay, Emily Adland, Anna Csala, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccinesRosalind Rowland, Geraldine A O'Hara, Matthew Hamill, et al.
Science Translational Medicine|April 13, 2022
NK cells limit therapeutic vaccine-induced CD8<sup>+</sup>T cell immunity in a PD-L1-dependent mannerMariana O Diniz, Anna Schurich, Senthil K Chinnakannan, et al.
Science Immunology|August 29, 2025
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccinesSam M Murray, Ali Amini, Helen Ferry, et al.
Hepatology (Baltimore, Md.)|November 14, 2025
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategiesRebecca Strain, Matthew Edmans, Gerardo Montalvo Zurbia-Flores, et al.
The Journal of General Virology|September 28, 2012
Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6Hongren Wang, Zhiguo Yuan, Eleanor Barnes, et al.
The Lancet. Gastroenterology & Hepatology|November 28, 2018
Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trialStuart Flanagan, Jan Kunkel, Victoria Appleby, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UKVictoria Hamill, Will Gelson, Douglas MacDonald, et al.
Pageof 23